A METHOD OF TREATING ACNE VULGARIS AND COMPOSITION CONTAINING CARBAMIDE PEROXIDE

Abstract: An improved method of treating acne vulgaris comprising administering a therapeutically effective amount of carbamide peroxide alone or in combination with one or more of a topical antibiotic, nicotinic acid or nicotinamide and compositions useful in said method.

Description: A METHOD OF TREATING ACNE VULGARIS AND COMPOSITION CONTAINING CARBAMIDE PEROXIDE The present invention relates to a composition for treating acne vulgaris. Acne vulgaris is an inflammatory disease of the pilosebaceous glands characterized by an eruption of the skin, often pustular in nature but not sup- prative. Acne is a common affliction of the adolescent and affects a small but significant percentage of the adult population. Acne lesions are of four basic types: comedones (blackheads or whiteheads) , papules, pustules, and cysts (or nodules) . Various topical agents are utilized in the treatment of acne and these include sulfur, resorcinol, salicylic acid, benzoyl peroxide, vitamin A " acid and topical antibiotics. Acne involvement results in unslightly lesions, par- ticularly on the face, and in some cases results in severe scarring. There are a variety of methods for treating acne vulgaris including topically applying various scrubbing or abrasive compositions, topically applying deep cleaning or astringent compositions and also ex¬ posure to ultraviolet radiation. Nevertheless, acne vulgaris is seldom cured and only can be contained with difficulty. Carbamide peroxide is an agent used to soften earwax for removal. .1 have tested topical for- mulations containing carbamide peroxide for effectiveness in acne and found surprisingly that carbamide peroxide applied topically to the skin is useful in the treat¬ ment of acne vulgaris. Also, surprisingly carbamide peroxide achieves such beneficial effects without much of the irritating and sensitizing effects of benzoyl peroxide. I have also found that combinations of car¬ bamide peroxide with certain chemical agents known to be effective in treating acne are more effective in treating acne than would be expected by treatment with the individual agents themselves. Such formulations include combinations of carbamide peroxide and one or more of nicotinamide or topical antibiotics such as erythromycin base, clindamycin phosphate and tetra- cycline hydrochloride. The present invention provides a composition effective in decreasing the inflammatory lesions of acne vulgaris in human patients having such inflamma- tory lesions comprising a carrier containing a therapeuti¬ cally effective amount of carbamide peroxide in combina¬ tion with a therapeutically effective amount of one or more of a topical antibiotic, nicotinic acid or nicotin¬ amide. In the practice of this invention, topical solutions of carbamide peroxide in various organic vehicles such as a combination of ethyl alcohol and propylene glycol in which the active ingredient is present in the range of from about 1% to about 15% by volume of the carrier are prepared. Additionally topical solutions of carbamide peroxide in various organic carriers in concentrations ranging from 1 to 15% by volume of the carrier are in¬ corporated into various organic vehicles including solutions, lotions, creams, gels, and ointments along with one or more of the following ingredients: nicotinic acid or nicotinamide in concentrations of from 1% to 10% by volume of the carrier; erthromycin base in concentrations of from 1% to about 6% by volume of the carrier; clindamycin phosphate in con¬ centrations of from 1 to 5% by volume; tetracycline hydrochloride in concentrations of from 1 to 5% by volume of the carrier. Such carriers useful for the incorporation of carbamide peroxide include combina¬ tions of ethyl alcohol and propylene glycol as well as surface active agents such as lauryl ethers and lauryl esters. Applications of the carrier and ef¬ fective ingredient are made to the face of acne patients 2 to 4 times daily with the result that open and closed comedones (blackheads and whiteheads) are markedly reduced within two weeks. The following examples il- lustrate the present invention. Example 1 A 1% solution of carbamide peroxide was prepared in an alcohol-propylene glycol carrier. Twice daily topical application of this solution were self- administered by a 26 year old female patient suffering from acne vulgaris. After two weeks of treatment the comedone count on the patient's face had declined from 28 to 15. Example 2 A 20 year-old male applied 10% carbamide peroxide prepared in an alcohol gel containing 6% polyoxyethylene lauryl ether four times daily. After 10 days the number of comedones on his face had de¬ clined from 43 to 25 and by the end of four weeks of treatment he had only 18 comedones on his face. Example 3 A 30 year-old female with acne vulgaris ap¬ plied a 5% by volume solution of carbamide peroxide in a 70% ethyl alcohol and 30% propylene glycol carrier. The product was applied to all involved areas of the face and back twice daily. Before treatment this patient had 64 comedones on the face and back but after two weeks of treatment she had only 41 comedones in these areas. Example 4 A 2.5% carbamide peroxide cream was prepared containing water, propylene glycol, bentonite, glycerol stearate, isopropyl myristate and cellulose gum and ap¬ plied twice daily to the skin of a 24 year-old male with many comedones on his forehead. After two weeks of such treatment the number of comedones on his forehead had declined from 28 to 12. Example 5 A 26 year-old male who had been unable to use 5 or 10% benzoyl peroxide preparations due to rashes each time he used them, applied a topical 5% carbamide peroxide preparation twice daily for eight weeks. The number of comedones declined over this treatment period from 46 to 29 at two weeks and to only 16 comedones after eight weeks of therapy. Example 6 An alcohol/aqueous solution containing 2.5% carbamide peroxide and 6% erythromycin was applied topically twice daily by a 30 year-old female with acne vulgaris consisting of both comedones (18) and papules and pustules (12) . After four weeks of treatment the patient's face was considerably clearer with only 8 comedones and 6 papules or pustules apparent. Example 7 A 14 year-old female with several comedones and 15 small acne pustules . and papules ' applied a sol¬ ution comprised of 10% carbamide peroxide and 2% erythromycin in an alcohol-propylene glycol carrier. After 8 weeks of one to twice daily treatment the sub¬ ject's face was free of all but 2 small acne papules. Example 8 A alcohol-propylene glycol vehicle containing 5% carbamide peroxide and 2% nicotinamide was applied four times daily by a 21 year -old male with a mixture of comedones and papulo-pustules on his face. After ten days of treatment his face was much improved and after four weeks of such treatment, it was almost com- pletely clear. Example 9 A 16 year-old male with moderate severe in¬ flammatory acne consisting of primarily papules and pustules as well as a lessor number of comedones ap¬ plied a gel containing 15% carbamide peroxide and 10% nicotinamide twice daily. The patient's lesions al¬ most completely cleared within ten (10) days but he had to discontinue the product because of excessive chapping. Example 10 Carbamide peroxide 5% and clindomycin phos¬ phate 1% were incorporated into an alcoholic gel con¬ taining 6% polyoxyetheylene lauryl ether and applied to the face twice daily by a 22 year-old male with acne vulgaris. This patient's comedone count decreased from 26 to 10 and the papulo-pustule count from 16 to 8 after 4 weeks of such treatment. Example 11 An aqueous/alcohol solution containing 10% carbamide peroxide and 2.5% clindamycin phosphate was applied once daily by a 24 year-old female with acne comedones, papules and pustules on her face. After two weeks of treatment she was noted to have greater than a 40% reduction in both comedones as well as papulo-pustules. Example 12 An aqueous/alcohol solution containing a salt of tetracyline such as tetracycline hydrochloride is also useful in amounts of about 1% to about 5% by vol¬ ume of the carrier when combined with an effective amount of carbamide peroxide. The present invention includes within the scope thereof pharmaceutical compositions suitable for topical administration having as an active ingredient thereof carbamide peroxide, the chemical formula of which is Also included in the scope of the invention is the com¬ bination of carbamide peroxide with one or more of nicotinic acid or nicotinamide or a topical antibiotic such as erythromycin base, clindamycin phosphate and tetracycline hydrochloride. Where appropriate a pharmaceutically acceptable carrier gel, or ointment is emplo ed. Liquid dosage forms for topical administration includes acceptable emulsions, solutions and suspensions containing volatile diluents commonly used in the art, such as alcohol, glycol and the like. Besides such diluents, topically applied compositions may also in- elude wetting agents, emulsifying and suspending agents.

Claims: CLAIMS 1. A method of decreasing inflammatory le¬ sions of acne vulgaris in human patients having such inflammatory lesions, comprising administering a ther¬ apeutically effective amount of carbamide peroxide to a patient having such open and closed comedones. 2. The method of claim 1, wherein said ad¬ ministration is topical with the carbamide peroxide being dispersed in a pharmaceutically acceptable carrier. 3. The method of claim 2, wherein the car¬ bamide peroxide is present in the amount of not less than about 1% by volume of the carrier. 4. The method of claim 2, wherein the car¬ bamide peroxide' is present in the range of between about 1% and about 15% by volume of the carrier. 5. The method of claim 2, wherein the carrier is selected from an alcohol or a glycol or mixtures thereof. 6. The method of claim 1, wherein the car¬ bamide peroxide is provided in combination with a therapeutically effective amount of one or more of a topical antibiotic, nicotinic acid or nicotinamide. 7. The method of claim 6, wherein said ad¬ ministration is topicai with the effective ingredients being dispersed in a pharmaceutically acceptable carrier. 8. The method of claim 7, wherein the ef¬ fective ingredients include erythromycin base present in the range of from about 1% to about 6% by volume of the carrier. 9. The method of claim 7, wherein the ef¬ fective ingredients include clindamycin phosphate present in the range of from about 1% to about 5% by volume of the carrier. 10. The method of claim 7, wherein the ef¬ fective ingredients include tetracycline hydrochloride present in the range of from about 1% to about 5% by volume. C- " I 11. The method of claim 7, wherein the ef¬ fective ingredients include nicotinamide present in the range of from about 1% to about 10% by volume of the carrier. 12. A topical ointment, cream or lotion containing carbamide peroxide in an amount sufficient to be therapeutically effective for the treatment of acne vulgaris including open a nd closed comedones. 13. The topical ointment cream or lotion of claim 12, wherein the carbamide peroxide is present in an amount not less than about 1% by volume of the in¬ active ingredients. 14. The topical ointment, cream or lotion of claim 13, wherein the carbamide peroxide is present in the range of from about 1% to about 15% by volume of the inactive ingredients. 15. A composition effective in decreasing the inflammatory lesions of acne vulgaris in human patients having such inflammatory lesions comprising a carrier containing a therapeutically effective amount of carbamide peroxide in combination with a therapeutical¬ ly effective amount of one or more of a topical anti¬ biotic, nicotinic acid or nicotinamide. 16. The composition of claim 15, wherein the effective ingredients include carbamide peroxide present in an amount not less than about 1% by volume of the carrier. 17. The composition of claim 15, wherein the effective ingredients include carbamide peroxide present in the range of from about 1% to about 15% by volume of the carrier. 18. The composition of claim 15, wherein the effective ingredients include erythromycin base present in the range of from about 1% to about 6% by volume of the carrier. 19. The composition of claim 15, wherein the effective ingredients include clindamycin phosphate present in the range of from about 1% to about 5% by volume of the carrier. 20. The composition of claim 15, wherein the effective ingredients include tetracycline hydrochloride present in the range of from about 1% to about 5% by volume of the carrier. 21. The composition of claim 15, wherein the effective ingredients include nicotinamide present in the range of from about 1% to about 10% by volume of the carrier. /

Inventors: BERNSTEIN JOEL E, BERNSTEIN, JOEL, E.
Applicants: BERNSTEIN JOEL E, BERNSTEIN, JOEL, E.
Application year: 1982
Main classification: A61K31
IPC codes: A61K8, A61K31, A61K33, A61Q19